AA
GILD icon

Altman Advisors’s Gilead Sciences GILD Stock Holding History

Altman Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Sell
21,992
-513
-2% -$71.8K 1.27% 20
2025
Q4 		$2.76M Buy
22,505
+186
+0.8% +$22.6K 1.04% 33
2025
Q3 		$2.48M Buy
22,319
+333
+2% +$37.9K 0.95% 41
2025
Q2 		$2.46M Buy
21,986
+716
+3% +$76.2K 1% 34
2025
Q1 		$2.27M Buy
21,270
+317
+2% +$32.7K 1.04% 28
2024
Q4 		$1.94M Buy
20,953
+78
+0.4% +$7.02K 0.83% 47
2024
Q3 		$1.75M Buy
20,875
+253
+1% +$19.3K 0.78% 62
2024
Q2 		$1.41M Buy
20,622
+554
+3% +$37K 0.8% 62
2024
Q1 		$1.46M Buy
20,068
+877
+5% +$67.4K 0.71% 72
2023
Q4 		$1.55M Sell
19,191
-132
-0.7% -$10.3K 0.82% 52
2023
Q3 		$1.45M Buy
+19,323
New +$1.49M 0.9% 39
2023
Q1 		$1.34M Buy
19,145
+364
+2% +$30.1K 1.23% 29
2022
Q4 		$1.64M Sell
18,781
-658
-3% -$52.1K 1.01% 27
2022
Q3 		$1.2M Buy
+19,439
New +$1.23M 0.76% 46
2020
Q4 		– Sell
-6,054
Closed -$383K – 85
2020
Q3 		$383K Sell
6,054
-24,723
-80% -$1.71M 0.27% 73
2020
Q2 		$2.37M Sell
30,777
-75
-0.2% -$5.75K 2.01% 18
2020
Q1 		$2.31M Buy
+30,852
New +$2.13M 2.14% 9

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Altman Advisors's GILD Position: Q1 2026 in Review

Altman Advisors reduced its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, selling an estimated $71.8K and leaving 21,992 shares worth $3.07M. The position accounts for 1.27% of the portfolio, ranked #20.

Altman Advisors first reported a position in GILD in Q1 2020 and has held it in 17 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Altman Advisors held 21,992 shares of Gilead Sciences worth $3.07M as of Q1 2026.
  • Altman Advisors sold 513 Gilead Sciences shares in Q1 2026, an estimated $71.8K.
  • Gilead Sciences made up 1.27% of Altman Advisors's portfolio in Q1 2026, its #20 holding.
  • Altman Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 17 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Altman Advisors's 13F filing for Q1 2026, filed 5 May 2026.